Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Journal of Viral Hepatitis|November 22, 2014
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trialM Buti, R Flisiak, J-H Kao, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 4, 2005
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004L Gambotti, D Batisse, N Colin-de-Verdiere, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control studyY Yazdanpanah, G De Carli, B Migueres, et al.
Revue D'Epidemiologie Et De Sante Publique|November 1, 2006
[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]Y Yazdanpanah, G De Carli, B Migueres, et al.
Gastroenterologie Clinique Et Biologique|March 26, 2002
[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]F Roudot-Thoraval, A Abergel, F Allaert, et al.
Gut|September 18, 2002
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levelsC Renou, P Halfon, S Pol, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.
Journal of Viral Hepatitis|May 20, 2003
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled studyI Portal, M Bourlière, P Halfon, et al.
Pageof 18